The S&P 500 healthcare sector climbed 0.7% and was the day's best performer.
Shares of Theravance
The day's flat activity follows a third straight week of gains on the major indexes, with both the Dow and S&P 500 setting record closing highs last week. The S&P 500 remains up 14.5% for the year so far.
While some analysts argue the long-term trend is still higher, many see momentum waning in the near term in the absence of positive catalysts. Volume has been lighter than average, and volatility has been low in recent days.
"Intraday volatility has essentially been nonexistent. I think it means people are really sitting on the sidelines right now seeing which way it's going to go," said Uri Landesman, president of Platinum Partners in New York.
The CBOE Volatility index ended down 0.3%.
More From This Section
The Dow Jones industrial average was down 26.81 points, or 0.18%, at 15,091.68. The Standard & Poor's 500 Index was up 0.07 points at 1,633.77. The Nasdaq Composite Index was up 2.21 points, or 0.06%, at 3,438.79.
Among the day's decliners, Yum Brands Inc
Helping to limit the market's downside, retail sales rose 0.1% in April, better than the 0.3% drop that had been expected, and returning to growth following a decline in March. Excluding autos, gasoline and building materials, core sales rose 0.5%. Retail sales account for about 30% of US consumer spending.
Investors are at odds over whether positive economic data can help the market rise further, or whether it will spell the end of the Federal Reserve's monetary stimulus, which could derail the rally, said Joseph Tanious, global market strategist at J.P. Morgan Funds.
Other data showed business inventories were unchanged in March for a second straight month, versus expectations of 0.3% rise, suggesting restocking could help second-quarter economic growth.
Earnings have been mostly better than expected. With 90% of the S&P 500 having reported, 67.2% of companies have topped earnings expectations, according to Thomson Reuters data, even with the average over the past four quarters. Only 46.9% have beaten revenue expectations, below the 52% average over the past four quarters.
US-listed shares of Perion Network